Related references
Note: Only part of the references are listed.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
Adnan M. Subei et al.
CNS DRUGS (2015)
Decreased serum concentrations of sphingosine-1-phosphate in sepsis
Martin Sebastian Winkler et al.
CRITICAL CARE (2015)
Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels
Yugesh Kharel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
John Camm et al.
AMERICAN HEART JOURNAL (2014)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Yasuyuki Kihara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
An update on the biology of sphingosine 1-phosphate receptors
Victoria A. Blaho et al.
JOURNAL OF LIPID RESEARCH (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis
Thomas Gobbetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis
Jessica Lauriol et al.
SCIENCE SIGNALING (2014)
CHARACTERIZATION OF CARDIAC DYSFUNCTION IN SEPSIS: AN ONGOING CHALLENGE
Ahmed Zaky et al.
SHOCK (2014)
Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat
Cornelia Lundblad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2013)
Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor
Areeg I. Khan et al.
DISEASE MODELS & MECHANISMS (2013)
Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse
Sina M. Coldewey et al.
DISEASE MODELS & MECHANISMS (2013)
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor
Sina M. Coldewey et al.
KIDNEY INTERNATIONAL (2013)
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate
Yugesh Kharel et al.
BIOCHEMICAL JOURNAL (2012)
Sphingosine 1-phosphate in coagulation and inflammation
Hideru Obinata et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Sphingosine-1-phosphate signaling and its role in disease
Michael Maceyka et al.
TRENDS IN CELL BIOLOGY (2012)
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
Sunil B. Kumaraswamy et al.
CRITICAL CARE (2012)
Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system
Mirjam Schuchardt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
RhoA protects the mouse heart against ischemia/reperfusion injury
Sunny Yang Xiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Septic cardiomyopathy
Antoine Vieillard-Baron
ANNALS OF INTENSIVE CARE (2011)
Protective Role of Peroxisome Proliferator-activated Receptor-β/δ in Septic Shock
Amar Kapoor et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
AUGMENTATION OF PLATELET AND ENDOTHELIAL CELL ENOS ACTIVITY DECREASES SEPSIS-RELATED NEUTROPHIL-ENDOTHELIAL CELL INTERACTIONS
Raymond Khan et al.
SHOCK (2010)
Targeting sphingosine-1-phosphate signalling for cardioprotection
Simon Kennedy et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
New players on the center stage: Sphingosine 1-phosphate and its receptors as drug targets
Andrea Huwiler et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Focal Adhesion Kinase as a RhoA-activable Signaling Scaffold Mediating Akt Activation and Cardiomyocyte Protection
Dominic P. Del Re et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
Jesus Blanco et al.
CRITICAL CARE (2008)
HDL and its sphingosine-1-phosphate content in cardioprotection
Petra Keul et al.
HEART FAILURE REVIEWS (2007)
Autocrine and paracrine roles of sphingosine-1-phosphate
Sergio E. Alvarez et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
Volker Brinkmann
PHARMACOLOGY & THERAPEUTICS (2007)
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury
Christopher K. Means et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo
Neil Cartwright et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples
Helmut Schmidt et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
P Bandhuvula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
S1P1-selective in vivo-active agonists from high-throughput screening:: Off-the-shelf chemical probes of receptor interactions, signaling, and fate
EJ Jo et al.
CHEMISTRY & BIOLOGY (2005)
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion
DJ Hausenloy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury
XQ Peng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock
MC McDonald et al.
SHOCK (2003)
Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist
M Osada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock
GW Cockerill et al.
FASEB JOURNAL (2001)
Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3
H Okamoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5
SZ An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
